Ginkgo Bioworks Holdings (DNA) Cash from Investing Activities (2020 - 2026)

Ginkgo Bioworks Holdings' Cash from Investing Activities history runs 7 years deep, the most recent figure standing at $23.1 million for Q1 2026.

• Quarterly Cash from Investing Activities rose 111.64% year-over-year to $23.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$18.5 million (up 92.58% YoY) and the FY2025 annual result came in at -$240.3 million, down 286.09% from the prior year.
• Cash from Investing Activities was $23.1 million for Q1 2026 at Ginkgo Bioworks Holdings, down from $95.1 million in the prior quarter.
• Across five years, Cash from Investing Activities topped out at $95.1 million in Q4 2025 and bottomed at -$198.7 million in Q1 2025.
• A 5-year average of -$25.1 million and a median of -$14.7 million in 2022 frame the typical range for Cash from Investing Activities.
• Peak annual rise in Cash from Investing Activities reached 826.78% in 2025, while the deepest fall reached 1540.66% in 2025.
• Ginkgo Bioworks Holdings' Cash from Investing Activities stood at $29.7 million in 2022, then sank by 256.94% to -$46.7 million in 2023, then jumped by 71.97% to -$13.1 million in 2024, then jumped by 826.78% to $95.1 million in 2025, then sank by 75.68% to $23.1 million in 2026.
• Business Quant data shows DNA's Cash from Investing Activities at $23.1 million in Q1 2026, $95.1 million in Q4 2025, and -$72.8 million in Q3 2025.